First Time Loading...

NanJing Pharmaceutical Co Ltd
SSE:600713

Watchlist Manager
NanJing Pharmaceutical Co Ltd Logo
NanJing Pharmaceutical Co Ltd
SSE:600713
Watchlist
Price: 4.9 CNY 0.41% Market Closed
Updated: May 17, 2024

NanJing Pharmaceutical Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NanJing Pharmaceutical Co Ltd
Gross Profit Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
NanJing Pharmaceutical Co Ltd
SSE:600713
Gross Profit
¥3.2B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
10%
Sinopharm Group Co Ltd
HKEX:1099
Gross Profit
¥48.5B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
14%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Gross Profit
¥30B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
11%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Gross Profit
¥11.4B
CAGR 3-Years
4%
CAGR 5-Years
9%
CAGR 10-Years
17%
C
China National Medicines Corp Ltd
SSE:600511
Gross Profit
¥3.9B
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
18%
Huadong Medicine Co Ltd
SZSE:000963
Gross Profit
¥12.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
14%

See Also

What is NanJing Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
3.2B CNY

Based on the financial report for Mar 31, 2024, NanJing Pharmaceutical Co Ltd's Gross Profit amounts to 3.2B CNY.

What is NanJing Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
10%

Over the last year, the Gross Profit growth was 0%. The average annual Gross Profit growth rates for NanJing Pharmaceutical Co Ltd have been 8% over the past three years , 9% over the past five years , and 10% over the past ten years .